Dr. Nakhle Saba
Claim this profileTulane Cancer Center
Studies Lymphoma
Studies Mixed-Cell Lymphoma
17 reported clinical trials
42 drugs studied
Area of expertise
1Lymphoma
CD30 negative
HTLV-1 positive
2Mixed-Cell Lymphoma
CCND1 positive
t(11;14) positive
Affiliated Hospitals
Clinical Trials Nakhle Saba is currently running
Lenalidomide + Nivolumab
for Lymphoma
This trial tests a combination of drugs to treat a rare brain cancer. The treatment aims to starve the tumor, boost the immune system, and stop cancer cells from growing. It targets patients with primary CNS lymphoma who may not respond well to standard treatments.
Recruiting1 award Phase 119 criteria
Rituximab vs Mosunetuzumab
for Follicular Lymphoma
This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. It is not yet known if giving rituximab or mosunetuzumab works better in treating patients with follicular lymphoma with a low tumor burden.
Recruiting2 awards Phase 313 criteria
More about Nakhle Saba
Clinical Trial Related8 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Nakhle Saba has experience with
- Rituximab
- Cyclophosphamide
- Brentuximab Vedotin
- LOXO-305
- Dexamethasone
- Lenalidomide
Breakdown of trials Nakhle Saba has run
Lymphoma
Mixed-Cell Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nakhle Saba specialize in?
Nakhle Saba focuses on Lymphoma and Mixed-Cell Lymphoma. In particular, much of their work with Lymphoma has involved CD30 negative patients, or patients who are HTLV-1 positive.
Is Nakhle Saba currently recruiting for clinical trials?
Yes, Nakhle Saba is currently recruiting for 8 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Nakhle Saba has studied deeply?
Yes, Nakhle Saba has studied treatments such as Rituximab, Cyclophosphamide, Brentuximab Vedotin.
What is the best way to schedule an appointment with Nakhle Saba?
Apply for one of the trials that Nakhle Saba is conducting.
What is the office address of Nakhle Saba?
The office of Nakhle Saba is located at: Tulane Cancer Center, New Orleans, Louisiana 70112 United States. This is the address for their practice at the Tulane Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.